Associations of plasma biomarkers of Alzheimer's pathology with longevity and healthspan
Zhang, B.; LaCroix, A. Z.; Resnick, S. M.; Nguyen, S.; Ferrucci, L.; Libermann, T. A.; Ngo, L.; Casanova, R.; Reiner, A. P.; Li, D.; Nievergelt, C.; Maihofer, A.; McEvoy, L. K.; Shadyab, A. H.
Show abstract
Plasma biomarkers of Alzheimers pathology have been studied in relation to cognitive decline and dementia, but no prior study has examined their associations with longevity or healthspan. In this cohort study of older women (N=2,576), we examined plasma biomarkers measured at baseline when women were cognitively unimpaired. We found that plasma biomarkers were associated with both exceptional longevity and healthspan, defined as survival to age 90 without cognitive impairment. Elevated levels of plasma p-tau217 (OR, 0.58; 95% CI, 0.50-0.68), p-tau181 (OR, 0.81; 95% CI, 0.71 - 0.93), NfL (OR, 0.70; 95% CI, 0.60 - 0.82) and GFAP (OR, 0.78; 95% CI, 0.68 - 0.90) were all associated with reduced odds of healthspan; findings survived adjustment for multiple comparisons. These findings suggest that plasma biomarkers may not only reflect ADRD pathology but also systemic aging processes that underlie lifespan and healthspan, underscoring their potential value as novel biomarkers of aging.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Plasma biomarkers of Alzheimer’s disease predict cognitive decline and could improve clinical trials in the cognitively unimpaired elderly 96%
- Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease 95%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 93%
Similar papers in this journal
- Association of a pace of aging epigenetic clock with rate of cognitive decline in the Framingham Heart Study Offspring Cohort 95%
- Cross-sectional study of plasma phosphorylated Tau 217 in persons without dementia 95%
- Blood metabolites predicting Mild Cognitive Impairment in the Study of Latinos-Investigation of Neurocognitive Aging (HCHS/SOL) 95%
Similar papers in this journal
- Socioeconomic Status, Biological Aging, and Memory in a Diverse National Sample of Older US Men and Women 95%
- CSF Aβ38 levels are associated with Alzheimer-related decline: implications for γ-secretase modulators 93%
- Physical activity and risk of Alzheimer’s disease: a two-sample Mendelian randomization study 91%